TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07822321: Brexanolone Lifting Outcomes Of Moms

Sponsor: Lipocine Inc. · Phase: PHASE3 · Area: CNS_NEUROLOGY · Target Enrollment: 120 pts

Competing Trials Overlap

11 Active Trials

Excess Burn Exposure

$3,305,760

Rescue Site Savings

+$2,203,840

Unlock Full NCT07822321 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07822321 Rescue Dossier →